Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
According to a recent survey conducted on pediatric antibiotic administration, there are significant discrepancies in the frequency and dosage of antibiotics prescribed by healthcare providers for children with respiratory infections. While some clinicians prescribe antibiotics frequently as a precautionary measure, others prefer to wait and see if symptoms persist or worsen before administering any medication. This disparity not only exposes children to unnecessary risks associated with antimicrobial resistance, but it also highlights the need for further education and guidelines regarding appropriate prescription practices. Moreover, parents play an equally important role in ensuring proper antibiotic administration by following instructions carefully and completing the full course of treatment even after symptoms subside.
1.
Inner Thoughts of Leonard Bernstein, the "Maestro".
2.
In CML Patients With New Diagnoses, STAMP Inhibitor Outperforms Imatinib and Second-Gen TKIs.
3.
Obesity linked to subsequent neoplasms in childhood cancer survivors
4.
While most cancer screenings won't prolong lives, there are still good reasons to continue screening.
5.
In Acute Leukemia With Heavily Pretreated Patients, Menin Inhibitor Yields 63 Percent ORR.
1.
Colon Cancer Staging: What You Need to Know
2.
Revolutionizing Cancer Treatment with Trilaciclib: How a New Drug is Transforming Outcomes
3.
Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology
4.
Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment
5.
Tremelimumab: A Potential Breakthrough in Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
2.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
3.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
4.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
5.
Should We Use DARA Up Front As First-Line Therapy in MM?
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge